What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
His primary areas of investigation include Kidney disease, Internal medicine, Intensive care medicine, Endocrinology and Dialysis.
The concepts of his Kidney disease study are interwoven with issues in Diabetes mellitus, Nephropathy, Disease and Renal function.
As part of the same scientific family, David C. Wheeler usually focuses on Internal medicine, concentrating on Placebo and intersecting with Surgery.
David C. Wheeler has researched Intensive care medicine in several fields, including Guideline, Clinical trial, Pathology, Phosphorus metabolism and Blood pressure.
His Endocrinology research incorporates themes from Proinflammatory cytokine, Monocyte and Hazard ratio.
His research in Dialysis intersects with topics in Ezetimibe and Simvastatin.
His most cited work include:
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial (1691 citations)
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
- Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes (997 citations)
What are the main themes of his work throughout his whole career to date?
David C. Wheeler mainly focuses on Internal medicine, Kidney disease, Intensive care medicine, Endocrinology and Renal function.
His studies deal with areas such as Gastroenterology and Cardiology as well as Internal medicine.
The study incorporates disciplines such as Diabetes mellitus, Type 2 diabetes, Randomized controlled trial, Disease and Dialysis in addition to Kidney disease.
His Type 2 diabetes research is multidisciplinary, relying on both Placebo and Nephropathy.
The Intensive care medicine study combines topics in areas such as Guideline, Clinical trial and Transplantation, Kidney transplantation.
His Renal function study combines topics in areas such as Dapagliflozin and Urology.
He most often published in these fields:
- Internal medicine (51.99%)
- Kidney disease (42.83%)
- Intensive care medicine (21.31%)
What were the highlights of his more recent work (between 2017-2021)?
- Kidney disease (42.83%)
- Internal medicine (51.99%)
- Intensive care medicine (21.31%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Kidney disease, Internal medicine, Intensive care medicine, Diabetes mellitus and Type 2 diabetes.
His Kidney disease study incorporates themes from Renal function, Nephropathy, Disease, Dapagliflozin and Dialysis.
Internal medicine is closely attributed to Canagliflozin in his work.
His Intensive care medicine research is multidisciplinary, incorporating elements of Guideline, Health care, Sudden cardiac death and Kidney transplantation.
His biological study spans a wide range of topics, including Kidney, Risk factor and Urology.
His Type 2 diabetes study integrates concerns from other disciplines, such as Placebo, Albuminuria, Adverse effect and Mace.
Between 2017 and 2021, his most popular works were:
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (1296 citations)
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
- Dapagliflozin in Patients with Chronic Kidney Disease (245 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Diabetes mellitus
His scientific interests lie mostly in Kidney disease, Internal medicine, Diabetes mellitus, Renal function and Intensive care medicine.
David C. Wheeler interconnects Dialysis, Guideline, Nephropathy and Disease in the investigation of issues within Kidney disease.
His work on Cardiology expands to the thematically related Internal medicine.
His study in Renal function is interdisciplinary in nature, drawing from both Renal replacement therapy and Hyperkalemia.
The study incorporates disciplines such as Coronary artery disease, Lupus nephritis and Hemodialysis in addition to Intensive care medicine.
His work in Type 2 diabetes covers topics such as Urology which are related to areas like Adverse effect, Placebo and Placebo-controlled study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
